bioMérieux

Welcome to the bioMérieux Clinical Diagnostics website
“ Empowering clinical decisions ”
bioMérieux
bioMérieux provides diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. More

bioMérieux in ...


SPOTLIGHT



bioMérieux's Myla® Named as Finalist in the 2012 Medical Design Excellence Awards

Myla middleware recognized for groundbreaking innovation in In Vitro Diagnostics

Our Areas of Expertise

Cancer Cardiovascular Diseases Healthcare Associated Infections HIV Sepsis Tuberculosis

NEWS

May 3, 2012
bioMérieux Completes its VIDAS® Hepatitis Panel with a New Test for the Diagnosis of Hepatitis C

April 12, 2012
bioMérieux’s Myla® Named as Finalist in the 2012 Medical Design Excellence Awards

November 18, 2011
bioMérieux Initiative to Support European Antibiotic Awareness Day

November 8, 2011
bioTheranostics’ CancerTYPE ID® Linked with Improved Clinical Outcome and Longer Survival

July 19, 2011
bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients

June 30, 2011
World HAI Forum: Global Call to Action to Fight Antibiotic Resistance